Nonalcoholic steatohepatitis (NASH) Digestive System Other specified inflammatory liver diseases
Conditions
Interventions
Patients with a diagnosis of NAFLD prospectively attending the liver clinic will be approached and asked if they would like to participate. If in agreement, they will be asked to sign a consent form.
Sponsors
Hull University Teaching Hospitals NHS Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. 18 years or older on day of consent 2. Must be diagnosed with NAFLD with no liver biopsy planned (group 1) or Must be diagnosed with NAFLD with a planned liver biopsy (group 2) or Must not have a diagnosis of NAFLD (group 3)
Exclusion criteria
Exclusion criteria: 1. Must be less than 80 years old on day of consent 2. Unable to provide informed consent 3. Must not have a confirmed diagnosis of any liver disease other than NAFLD (group 1 and 2) 4. Must not have a diagnosis of any liver disease (group 3)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Journey mapping of the sample from clinic to lab to final result, to demonstrate logistical feasibility 2. Patient acceptability of having the test, assessed by direct questioning | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of participants' Glyco and liver biopsy results, alongside other clinical data, to determine if there is preliminary evidence of correlation (not statistically powered) | — |
Countries
England, United Kingdom
Outcome results
None listed